IOL CHEMICALS & PHARM. share price has zoomed 7% and is presently trading at Rs 437.4.
Meanwhile, the BSE HEALTHCARE index is at 37,289.9 (up 0.1%).
Among the top gainers in the BSE HEALTHCARE index today are J.B.Chemicals (up 2.4%) and ALEMBIC PHARMA (up 2.2%).
MAX HEALTHCARE INSTITUTE (down 1.5%) and KIMS (down 0.6%) are among the top losers today.
Over the last one year, IOL CHEMICALS & PHARM. has moved up from Rs 415.2 to Rs 437.4, registering a gain of Rs 22.2 (up 5.3%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,634.3 to 37,289.9, registering a gain of 45.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 86.3%), Cadila Healthcare (up 83.7%) and CAPLIN POINT (up 83.5%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,620.3 (up 0.2%).
The top gainers among the BSE Sensex today are HCl Tech. (up 1.2%) and Bharti Airtel (up 1.2%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,176.0 (up 0.1%). Wipro and ONGC are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,915.4 to 79,620.3, registering a gain of 15,704.9 points (up 24.6%).
IOL CHEMICALS & PHARM. net profit fell 57.4% YoY to Rs 276 million for the quarter ended March 2024, compared to a profit of Rs 648 million a year ago. Net sales declined 14.2% to Rs 5,039 million during the period as against Rs 5,872 million in January-March 2023.
For the year ended March 2023, IOL CHEMICALS & PHARM. reported 17.0% decrease in net profit to Rs 1,391 million compared to net profit of Rs 1,677 million during FY22. Revenue of the company grew 1.5% to Rs 22,171 million during FY23.
The current Price to earnings ratio of IOL CHEMICALS & PHARM., based on rolling 12 month earnings, stands at 19.1.
Equitymaster requests your view! Post a comment on "IOL CHEMICALS & PHARM. Gains 7%; BSE HEALTHCARE Index Up 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!